Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies

Background: GEMINI-1 and GEMINI-2 (ClinicalTrials.gov, NCT02831673 and NCT02831764, respectively) are double-blind, multicenter, phase III studies that demonstrated the non-inferiority of once-daily dolutegravir + lamivudine to dolutegravir + tenofovir disoproxil fumarate/emtricitabine in achieving...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Mounir Ait-Khaled, Juan Sierra Madero, Vicente Estrada, Roberto Gulminetti, Debbie Hagins, Hung-Chin Tsai, Choy Man, Jörg Sievers, Richard Grove, Andrew Zolopa, Brian Wynne, Jean van Wyk
Format:	Artigo
Sprog:	Inglês
Udgivet:	Taylor & Francis Group 2021-12-01
Serier:	HIV Research & Clinical Practice
Fag:	2-drug regimen integrase strand transfer inhibitor nucleoside reverse transcriptase inhibitor antiretroviral therapy virologic suppression
Online adgang:	http://dx.doi.org/10.1080/25787489.2021.2016303
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!